Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
Background: A significant proportion of lupus nephritis patients develop chronic kidney disease (CKD) and progressive kidney fibrosis, for which there is no specific treatment. We previously reported that mycophenolate or rapamycin monotherapy showed comparable efficacy in suppressing kidney fibrosi...
| 發表在: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2022-04-01
|
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fphar.2022.866077/full |
